Foundation and the UroTeragLATAM Foundation have signed a Memorandum of Understanding during the WFNMB congress in Cartagena, Colombia to collaborate on advancing Theranostics education through the ...
As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...
First radiotherapeutic agent developed by Radiopharm Ventures, the joint venture between Radiopharm Theranostics and MD Anderson Cancer Center ...
A new partnership will create a theranostics health care platform in the region with radiopharmaceutical production and therapy, molecular imaging, and clinical trials all at the same location. One ...
CNW/ - AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first patient in Radiopharm Theranostics' ...
The strategic partnership will also support the WHO resolution WHA78.13 with the aim to improve access to medical imaging and nuclear ...
Grand Rapids-based BAMF Health is partnering with multiple Kansas City health organizations to create a state-of-the-art ...
The University of Kansas Health System, KU Medical Center, Children's Mercy and BAMF Health are partnering to develop a theranostics platform for adult and pediatric patients.
For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options. For patients with prostate cancer, there are many treatment ...
New York, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Theranostics: Global Markets" - https://www.reportlinker.com ...
Theranostics is a term derived from a combination of the words therapeutics and diagnostics. In this emerging field of medicine, drugs and/or techniques are uniquely combined to simultaneously or ...
Personalized medicine player Theranostics is in the midst of a modest fund raise – it’s raising $1 million in equity, according to a regulatory filing. Not to be confused with biotech media darling ...